Discover verified cancer discoveries

Search and filter stories that passed editorial review. Evidence strength, regulatory status, and guideline position are shown separately and are never inferred from one another.

Filter discoveries

Results

Active filters:Clear all

1 verified discovery matches your filters.

FDA approves vorasidenib for IDH1/IDH2-mutant grade 2 glioma

Evidence stage: Later-Stage HumanRegulatory status: FDA Approved
Cancer type
Brain / CNS Cancer
Published
August 13, 2026

In the randomized, double-blind, placebo-controlled INDIGO trial, vorasidenib significantly delayed disease progression (by blinded independent review) and delayed the time to the next anticancer intervention, compared with placebo, in a…

Primary source cited

Last reviewed